A Short History of Thrombosis and Hemostasis: Part I (40th Year Celebratory Issue)

Emmanuel J. Favaloro

doi:10.1055/s-0034-1384768

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2014; 40(05): 521-525
DOI: 10.1055/s-0034-1384768

Preface

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

A Short History of Thrombosis and Hemostasis: Part I (40th Year Celebratory Issue)

Emmanuel J. Favaloro

¹Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, Australia

› Author Affiliations

Abstract

Full Text

References

References
1 Schiff D. Eulogy. Eberhard Mammen, M.D. 1930–2008. Semin Thromb Hemost 2008; 34: 305-306
2 Prasad A, Kwaan HC. In memoriam: a tribute to Eberhard F Mammen, M.D. (1930–2008). Semin Thromb Hemost 2008; 34 (8) 697-698
3 Fareed J, Walenga JM, Hoppensteadt DA, Bick RL, Messmore HL. Dr. Eberhard F. Mammen remembered: a great clinician-scientist, mentor, and friend. Semin Thromb Hemost 2008; 34: 128-130
4 Favaloro EJ. A tribute to Eberhard F. Mammen, M.D. (1930-2008). Semin Thromb Hemost 2008; 34 (8) 703-707
5 Kubisz P, Ruiz-Argüelles GJ, Stasko J, Holly P, Ruiz-Delgado GJ. Sticky platelet syndrome: history and future perspectives. Semin Thromb Hemost 2014; 40 (5) 526-534
6 Mammen EF. Sticky platelet syndrome. Semin Thromb Hemost 1999; 25 (4) 361-365
7 Cervellin G, Lippi G. Of MIs and men—a historical perspective on the diagnostics of acute myocardial infarction. Semin Thromb Hemost 2014; 40 (5) 535-543
8 Turner N, Nolasco L, Nolasco J, Sartain S, Moake J. Thrombotic microangiopathies and the linkage between von Willebrand factor and the alternative complement pathway. Semin Thromb Hemost 2014; 40 (5) 544-550
9 Moake JL, Rudy CK, Troll JH , et al. Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982; 307 (23) 1432-1435
10 Chapman K, Yuen S. Therapy for thrombotic thrombocytopenia purpura: past, present, and future. Semin Thromb Hemost 2014; 40 (1) 34-40
11 Favaloro EJ. Diagnosing von Willebrand disease: a short history of laboratory milestones and innovations, plus current status, challenges, and solutions. Semin Thromb Hemost 2014; 40 (5) 551-570
12 Favaloro EJ, Bradstock K, Castaldi P , et al. A Tribute to Professor Jerry Koutts, MD (Syd), BS, FRACP, FRCPA (1944–2013). Semin Thromb Hemost 2014; 40 (1) 1-4
13 Koutts J. A short history of diagnostic tests for von Willebrand disease: in memory of Barry Firkin (1930 to 2001) and Ted Zimmerman (1937 to 1988). Semin Thromb Hemost 2006; 32 (5) 445-455
14 Mammen EF. Von Willebrand's disease—history, diagnosis and management. Semin Thromb Hemost 1975; 2 (2) 61-84
15 Koutts J, Gude N, Firkin BG. The dynamic inter-relationship between factor VIII and von Willebrand factor. Thromb Res 1976; 8 (5) 533-541
16 Koutts J, Lavergne JM, Meyer D. Immunological evidence that human factor VIII is composed of two moieties. Br J Haematol 1977; 37 (3) 415-427
17 Koutts J, Howard MA, Firkin BG. Factor VIII physiology and pathology in man. In: Brown E, , ed. Progress in Hematology. XI. New York, NY: Grune and Stratton; 1979: 115-145
18 Irwin JF. Factor VIII in von Willebrand' disease. Semin Thromb Hemost 1975; 2 (2) 85-104
19 Franchini M, Mannucci PM. The history of hemophilia. Semin Thromb Hemost 2014; 40 (5) 571-576
20 Kasper CK, Mannucci PM, Bulyzhenkov V , et al. Hemophilia in the 1990s: principles of management and improved access to care. Semin Thromb Hemost 1992; 18 (1) 1-10
21 Kasper C, Aledort L, Counts R , et al. Letter: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975; 34 (3) 869-872
22 Favaloro EJ, Verbruggen B, Miller CH. Laboratory testing for factor inhibitors. Haemophilia 2014; ;(20) (Suppl. 04) 94-98
23 Favaloro EJ, Meijer P, Jennings I , et al. Problems and solutions in laboratory testing for hemophilia. Semin Thromb Hemost 2013; 39 (7) 816-833
24 Nurden AT. Platelet membrane glycoproteins: a historical review. Semin Thromb Hemost 2014; 40 (5) 577-584
25 Kwaan HC. From fibrinolysis to the plasminogen–plasmin system and beyond: a remarkable growth of knowledge, with personal observations on the history of fibrinolysis. Semin Thromb Hemost 2014; 40 (5) 585-591
26 Girolami A, Vidal J, Salagh M , et al. The old and the new in Prekallikrein deficiency: historical context and a family from Argentina with PK deficiency due to a new mutation (Arg541Gln) in exon 14 associated with a common polymorphysm (Asn124Ser) in exon 5. Semin Thromb Hemost 2014; 40 (5) 592-599
27 Targher G, Zoppini G, Bonora E, Moghetti P. Hemostatic and fibrinolytic abnormalities in polycystic ovary syndrome. Semin Thromb Hemost 2014; 40 (5) 600-618
28 Kwaan HC, McFadzean AJ, Cook J. Plasma fibrinolytic activity in cirrhosis of the liver. Lancet 1956; 270 (6908) 132-136
29 Carenza P, Girolami A. [Reserpine and thyroid function. Research with I-131]. Folia Endocrinol Mens Incretologia Incretoterapia 1959; 12: 651-664
30 Dioguardi N, Costa F, Mannucci PM. [Considerations on the cholecystokinetic activity of 1-phenyl-1-hydroxy-N-pentane]. Riforma Med 1963; 77: 561-564
31 Moake JL, Ahmed K, Bachur NR. Reversal by adenosine of ADP inhibition of platelet (Na+ + K+)-ATPase. Biochim Biophys Acta 1970; 219 (2) 484-485
32 Nurden AT, Butcher PD, Bredoux R, Caen JP. Platelet shape change: induction by trypsin and release of an acidic macroglycopeptide from washed human platelets and from those of three cases of Glanzmann's thrombasthenia. Haemostasis 1974; 3 (4) 212-223